The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe
Abstract
Polypharmacy, a common condition among the elderly, is associated with adverse outcomes, including increased healthcare costs, due to higher mortality, falls and hospitalizations rates, adverse drug reactions, drug-drug reactions and medication nonadherence. This study aims to evaluate the prevalence and factors related to polypharmacy in older adults across 17 European countries, plus Israel. In this cross-sectional analysis, we used data from participants aged 65 or more years from Wave 6 of the Survey of Health, Ageing, and Retirement in Europe (SHARE) database. Polypharmacy was defined as the concurrent use of five or more medications. Age, gender, education, physical inactivity, number of limitations with activities of daily living, network satisfaction, quality of life, depression, number of chronic diseases and difficulty taking medication variables were found to be associated with polypharmacy. Our results showed a prevalence of polypharmacy ranging from 26.3 to 39.9%. Switzerland, Croatia and Slovenia were the countries with the lowest prevalence, whereas Portugal, Israel and the Czech Republic were the countries where the prevalence of polypharmacy was the highest. Age, gender, number of limitations with activities of daily living, number of chronic diseases, quality of life, depression, physical inactivity, network satisfaction, difficulty in taking medications, years of education and shortage of money were significant variables associated with polypharmacy. Polypharmacy is a highly prevalent condition in the elderly population. Identification of variables associated with polypharmacy, such as those identified in this study, is important to identify and monitor elderly groups, which are most vulnerable to polypharmacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
Pinquart, M., & Sörensen, S. (2000) · Psychology and Aging · doi:10.1037/0882-7974.15.2.187 · Cited by 1,549
Factors affecting therapeutic compliance: A review from the patient’s perspective
Li, S.-C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1458 · Cited by 1,265
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176
Aging Biology and Geriatric Clinical Pharmacology
McLean, A. J., & Le Couteur, D. G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.4 · Cited by 771
Aging, frailty and age-related diseases
Fulop, T., Larbi, A., Witkowski, J. M., McElhaney, J., Loeb, M., Mitnitski, A., & Pawelec, G. (2010) · Biogerontology · doi:10.1007/s10522-010-9287-2 · Cited by 649
From COPD to chronic systemic inflammatory syndrome?
Fabbri, L. M., & Rabe, K. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61383-x · Cited by 635
Health benefits of physical activity in older patients: a review
Vogel, T., Brechat, P.-H., Leprêtre, P.-M., Kaltenbach, G., Berthel, M., & Lonsdorfer, J. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01957.x · Cited by 545
Jyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2116 · Cited by 417
Social Network Type and Subjective Well-being in a National Sample of Older Americans
Litwin, H., & Shiovitz-Ezra, S. (2011) · The Gerontologist · doi:10.1093/geront/gnq094 · Cited by 414
Nobili, A., Garattini, S., & Mannucci, P. M. (2011) · Journal of Comorbidity · doi:10.15256/joc.2011.1.4 · Cited by 300
Association between polypharmacy and falls in older adults: a longitudinal study from England
Dhalwani, N. N., Fahami, R., Sathanapally, H., Seidu, S., Davies, M. J., & Khunti, K. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016358 · Cited by 261
Polypharmacy: correlations with sex, age and drug regimen
Bjerrum, L., Søgaard, J., Hallas, J., & Kragstrup, J. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050445 · Cited by 251
Prevalence and predictors of polypharmacy among older primary care patients in Germany
Junius-Walker, U., Theile, G., & Hummers-Pradier, E. (2006) · Family Practice · doi:10.1093/fampra/cml067 · Cited by 237
Physical inactivity among older adults across Europe based on the SHARE database
Gomes, M., Figueiredo, D., Teixeira, L., Poveda, V., Paúl, C., Santos-Silva, A., & Costa, E. (2017) · Age and Ageing · doi:10.1093/ageing/afw165 · Cited by 237
Self-citationMethods for estimating the occurrence of polypharmacy by means of a prescription database
Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050329 · Cited by 196
Wikman, A., Wardle, J., & Steptoe, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018952 · Cited by 181
Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable
Salazar, J. A., Poon, I., & Nair, M. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.6.695 · Cited by 171
Leslie, K. O. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0511-oa · Cited by 162
Medication Use and Functional Status Decline in Older Adults: A Narrative Review
Peron, E. P., Gray, S. L., & Hanlon, J. T. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.10.002 · Cited by 144
Gender differences, polypharmacy, and potential pharmacological interactions in the elderly.
Venturini, C. D., Engroff, P., Ely, L. S., Zago, L. F. D. A., Schroeter, G., Gomes, I., Carli, G. A. D., & Morrone, F. B. (2011) · PubMed Central · doi:10.1590/s1807-59322011001100004 · Cited by 125
Factors associated with excessive polypharmacy in older people
Walckiers, D., der Heyden, J. V., & Tafforeau, J. (2015) · Archives of Public Health · doi:10.1186/s13690-015-0095-7 · Cited by 113
Wahrendorf, M., & Siegrist, J. (2010) · European Journal of Ageing · doi:10.1007/s10433-010-0154-4 · Cited by 112
Herr, M., Sirven, N., Grondin, H., Pichetti, S., & Sermet, C. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2276-5 · Cited by 109
Difficulty Taking Medications, Depression, and Health Status in Heart Failure Patients
Morgan, A. L., Masoudi, F. A., Havranek, E. P., Jones, P. G., Peterson, P. N., Krumholz, H. M., Spertus, J. A., & Rumsfeld, J. S. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.08.004 · Cited by 108
Stewart, D. C., Mair, A. R., Wilson, M., Kardas, P., Lewek, P., Alonso, A., McIntosh, J., & MacLure, K. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1265503 · Cited by 98
Self-citationPrevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study
Castioni, J., Marques-Vidal, P. M., Abolhassani, N., Vollenweider, P., & Waeber, G. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2793-z · Cited by 89
Social networks and subjective wellbeing among older Europeans: does age make a difference?
Litwin, H., & Stoeckel, K. J. (2012) · Ageing and Society · doi:10.1017/s0144686x12000645 · Cited by 85
Suominen‐Taipale, A. L., Martelin, T. P., Koskinen, S. V. P., Holmen, J., & Johnsen, R. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-110 · Cited by 64
Bahat, G., Tufan, F., Bahat, Z., Tufan, A., Aydin, Y., Akpınar, T. S., Nadir, S., Erten, N., & Karan, M. A. (2014) · Aging Clinical and Experimental Research · doi:10.1007/s40520-014-0229-8 · Cited by 50
Active and Healthy Ageing and Independent Living 2016
Illario, M., Vollenbroek-Hutten, M. M. R., Molloy, D. W., Menditto, E., Iaccarino, G., & Eklund, P. (2016) · Journal of Aging Research · doi:10.1155/2016/8062079 · Cited by 43
Self-citationActive and Healthy Ageing and Independent Living
Illario, M., Vollenbroek-Hutten, M., Molloy, D. W., Menditto, E., Iaccarino, G., & Eklund, P. (2015) · Journal of Aging Research · doi:10.1155/2015/542183 · Cited by 41
Self-citationMarengoni, A., Monaco, A., Costa, E. M., Cherubini, A., Prados‐Torres, A., Muth, C., Melis, R. J. F., Pasina, L., van der Cammen, T. J. M., Palmer, K., et al. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0387-9 · Cited by 39
Self-citationPrevalence and Geographic Variations of Polypharmacy Among West Virginia Medicaid Beneficiaries
Feng, X., Tan, X., Riley, B. L., Zheng, T., Bias, T. K., Becker, J. B., & Sambamoorthi, U. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017717017 · Cited by 34
Polypharmacy and Inappropriate Drug Use among Older People—a Systematic Review
Elmståhl, S., & Linder, H. (2013) · Healthy Aging & Clinical Care in the Elderly · doi:10.4137/hacce.s11173 · Cited by 32
Towers, A., Yeung, P., Stevenson, B., Stephens, C. V., & Alpass, F. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0756-y · Cited by 25
Polypharmacy, multimorbidity and the value of integrative medicine in public health
Jacobs, J., & Fisher, P. (2012) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2012.09.001 · Cited by 25
Social functioning, polypharmacy and depression in older Chinese primary care patients
Liu, C., Leung, D. S.-Y., & Chi, I. (2011) · Aging & Mental Health · doi:10.1080/13607863.2011.562174 · Cited by 24
Depression and drug utilization in an elderly population
Incalzi, R. A., Corsonello, A., Pedone, C., Corica, F., & Carbonin, P. (2005) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.1.1.55.53603 · Cited by 22
Health Status Assessment Completing the Clinical Database
Wu, A. W., Cagney, K. A., & John, P. D. S. (1997) · Journal of General Internal Medicine · doi:10.1007/s11606-006-5050-4 · Cited by 21
Niclós, G., Olivar, T., & Rodilla, V. (2017) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12386 · Cited by 21
How healthy is community-dwelling elderly population? Results from southern Italy
Guerriero, F., Orlando, V., Tari, D. U., Giorgio, A. D., Cittadini, A., Trifirò, G., & Menditto, E. (2015) · PubMed Central · doi:10.14273/unisa-708 · Cited by 20
Self-citationPredictors of Difficulty in Medication Intake in Europe: a Cross-country Analysis Based on SHARE
de Figueiredo, D. M. P., Teixeira, L., Poveda, V., Paúl, C., Santos‐Silva, A., & Costa, E. M. (2016) · Aging and Disease · doi:10.14336/ad.2015.0925 · Cited by 14
Self-citationCharalampopoulou, E., Kontogiorgis, C. A., Nena, E., Constantinides, T. K., & Kolios, G. C. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0449-z · Cited by 6
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
An overview of prevalence, determinants and health outcomes of polypharmacy
Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620933741 · Cited by 443
Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
Nicholson, K., Liu, W., Fitzpatrick, D., Hardacre, K. A., Roberts, S., Salerno, J., Stranges, S., Fortin, M., & Mangin, D. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(24)00007-2 · Cited by 263
Prokopidis, K., Giannos, P., Reginster, J. Y., Bruyere, O., Petrovic, M., Cherubini, A., Triantafyllidis, K. K., Kechagias, K. S., Dionyssiotis, Y., Cesari, M., et al. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13190 · Cited by 51
Metadata
- Authors
- Midão, L., Giardini, A., Menditto, E., Kardas, P., & Costa, E.
- Venue
- Archives of Gerontology and Geriatrics
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 78
- Pages
- 213-220
- ISSN
- 0167-4943 (ISSN-L)
- OpenAlex
- W2810797036
- Cited by
- 397
- References
- 44
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.